Eagle Harbor Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
982
-129
-12% -$44.2K 0.28% 100
2026
Q1
$391K Sell
1,111
-100
-8% -$35.6K 0.33% 93
2025
Q4
$396K Sell
1,211
-30
-2% -$9.52K 0.33% 90
2025
Q3
$350K Buy
1,241
+197
+19% +$57.1K 0.3% 99
2025
Q2
$291K Buy
1,044
+1
+0.1% +$283 0.28% 105
2025
Q1
$325K Buy
1,043
+39
+4% +$11.5K 0.33% 96
2024
Q4
$262K Buy
+1,004
New +$298K 0.26% 109

Other funds holding AMGN

Eagle Harbor Asset Management's AMGN Position: Q2 2026 in Review

Eagle Harbor Asset Management reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $44.2K and leaving 982 shares worth $356K. The position accounts for 0.28% of the portfolio, ranked #100.

Eagle Harbor Asset Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $396K in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Eagle Harbor Asset Management held 982 shares of Amgen worth $356K as of Q2 2026.
  • Eagle Harbor Asset Management sold 129 Amgen shares in Q2 2026, an estimated $44.2K.
  • Amgen made up 0.28% of Eagle Harbor Asset Management's portfolio in Q2 2026, its #100 holding.
  • Eagle Harbor Asset Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Eagle Harbor Asset Management's Amgen position peaked at $396K in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Eagle Harbor Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.